Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Colorcon
McKinsey
Baxter
Moodys

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Litigation Details for Onyx Therapeutics, Inc. v. Breckenridge Pharmaceutical Inc. (D. Del. 2016)

See Plans and Pricing

« Back to Dashboard

Onyx Therapeutics, Inc. v. Breckenridge Pharmaceutical Inc. (D. Del. 2016)

Docket   Start Trial Date Filed 2016-10-27
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand None Referred To
Parties BRECKENRIDGE PHARMACEUTICAL INC.; ONYX THERAPEUTICS, INC.
Patents 7,232,818; 7,417,042; 7,491,704; 7,737,112; 8,129,346; 8,207,125; 8,207,126; 8,207,127; 8,207,297
Attorneys Jack B. Blumenfeld; Maryellen Noreika
Firms Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Onyx Therapeutics, Inc. v. Breckenridge Pharmaceutical Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .
Biologic Drugs cited in Onyx Therapeutics, Inc. v. Breckenridge Pharmaceutical Inc.
The biologic drug covered by the patents cited in this case is   Start Trial .

Details for Onyx Therapeutics, Inc. v. Breckenridge Pharmaceutical Inc. (D. Del. 2016)

Date Filed Document No. Description Snippet Link To Document
2016-10-27 1 12. United States Patent No. 7,232,818 (the “’818 Patent”), entitled “Compounds For Enzyme Inhibition…Product prior to the expiration of U.S. Patent Nos. 7,417,042; 7,232,818; 7,491,704; 7,737,112; 8,129,346;… COUNT II: INFRINGEMENT OF U.S. PATENT NO. 7,232,818 48. Plaintiff hereby realleges… THE PATENTS-IN-SUIT 11. United States Patent No. 7,417,042 (the “’042 Patent”), entitled… This is a civil action for patent infringement under the patent laws of the United States, Title External link to document
2019-05-16 25 ~Util - Terminate Civil Case enjoined from infringing United States Patent Numbers 7,417,042, 7,737,112, and 8,207,125, on its own … 27 October 2016 1:16-cv-01001 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Express Scripts
Moodys
Johnson and Johnson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.